Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

BACKGROUND In the National Polyp Study (NPS), colorectal cancer was prevented by colonoscopic removal of adenomatous polyps. We evaluated the long-term effect of colonoscopic polypectomy in a study on mortality from colorectal cancer. METHODS We included in this analysis all patients prospectively referred for initial colonoscopy (between 1980 and 1990) at NPS clinical centers who had polyps (adenomas and nonadenomas). The National Death Index was used to identify deaths and to determine the cause of death; follow-up time was as long as 23 years. Mortality from colorectal cancer among patients with adenomas removed was compared with the expected incidence-based mortality from colorectal cancer in the general population, as estimated from the Surveillance Epidemiology and End Results (SEER) Program, and with the observed mortality from colorectal cancer among patients with nonadenomatous polyps (internal control group). RESULTS Among 2602 patients who had adenomas removed during participation in the study, after a median of 15.8 years, 1246 patients had died from any cause and 12 had died from colorectal cancer. Given an estimated 25.4 expected deaths from colorectal cancer in the general population, the standardized incidence-based mortality ratio was 0.47 (95% confidence interval [CI], 0.26 to 0.80) with colonoscopic polypectomy, suggesting a 53% reduction in mortality. Mortality from colorectal cancer was similar among patients with adenomas and those with nonadenomatous polyps during the first 10 years after polypectomy (relative risk, 1.2; 95% CI, 0.1 to 10.6). CONCLUSIONS These findings support the hypothesis that colonoscopic removal of adenomatous polyps prevents death from colorectal cancer. (Funded by the National Cancer Institute and others.).

[1]  Harminder Singh,et al.  Risk of developing colorectal cancer following a negative colonoscopy examination: evidence for a 10-year interval between colonoscopies. , 2006, JAMA.

[2]  D. Lieberman A call to action--measuring the quality of colonoscopy. , 2006, The New England journal of medicine.

[3]  A. Jemal,et al.  Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates , 2010, Cancer.

[4]  D. Ransohoff,et al.  How Much Does Colonoscopy Reduce Colon Cancer Mortality? , 2009, Annals of Internal Medicine.

[5]  J. Faivre,et al.  Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening , 2001, British Journal of Cancer.

[6]  Robert H Fletcher,et al.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. , 2006, CA: a cancer journal for clinicians.

[7]  S. Moss,et al.  Randomised controlled trial of faecal-occult-blood screening for colorectal cancer , 1989, The Lancet.

[8]  E T Stewart,et al.  Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. , 1993, The New England journal of medicine.

[9]  Marcin Polkowski,et al.  Quality indicators for colonoscopy and the risk of interval cancer. , 2010, The New England journal of medicine.

[10]  D. Ransohoff,et al.  Five-Year risk of colorectal neoplasia after negative screening colonoscopy , 2008, Acta Endoscopica.

[11]  H. Brenner,et al.  Protection from colorectal cancer after colonoscopy: Population-based case-control study , 2010 .

[12]  Charles J. Kahi,et al.  Effect of screening colonoscopy on colorectal cancer incidence and mortality. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  L M Schuman,et al.  Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. , 1993, The New England journal of medicine.

[14]  J. Church,et al.  Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer , 2002, American Journal of Gastroenterology.

[15]  M. Diebold,et al.  [Management of malignant polyps]. , 1998, Gastroenterologie clinique et biologique.

[16]  T. Church,et al.  Colorectal cancer deaths as determined by expert committee and from death certificate: a comparison. The Minnesota Study. , 1999, Journal of clinical epidemiology.

[17]  Jane Wardle,et al.  Wide variation in adenoma detection rates at screening flexible sigmoidoscopy. , 2004, Gastroenterology.

[18]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[19]  D. Gyrd-Hansen,et al.  Analysis of screening data: colorectal cancer. , 1997, International journal of epidemiology.

[20]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[21]  E. Feuer,et al.  A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. , 1994, Journal of clinical epidemiology.

[22]  Deborah Schrag,et al.  Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. , 2005, Journal of the National Cancer Institute.

[23]  L. Rabeneck,et al.  Endoscopist specialty is associated with incident colorectal cancer after a negative colonoscopy. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[24]  A. Zauber,et al.  High-quality colonoscopies must be an integral part of screening and surveillance programs. , 2006, Gastroenterology.

[25]  E. Kliewer,et al.  The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. , 2010, Gastroenterology.

[26]  A. Neugut,et al.  Colonoscopy vs sigmoidoscopy screening: getting it right. , 2010, JAMA.

[27]  P. Allen,et al.  Studying cancer in minorities , 2011, Cancer.

[28]  R. Pearson Low Risk of Colorectal Cancer and Advanced Adenomas More Than 10 Years After Negative Colonoscopy , 2010 .

[29]  P. Rothwell,et al.  Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials , 2011, The Lancet.

[30]  J. Meyerhardt,et al.  Aspirin dose and duration of use and risk of colorectal cancer in men. , 2008, Gastroenterology.

[31]  A. Algra,et al.  Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials , 2010, The Lancet.

[32]  Tim Byers,et al.  Colorectal cancer in patients under close colonoscopic surveillance. , 2005, Gastroenterology.

[33]  D. Ransohoff,et al.  Adverse Events After Outpatient Colonoscopy in the Medicare Population , 2009, Annals of Internal Medicine.

[34]  Jahn M. Nesland,et al.  Morphologic Reappraisal of Serrated Colorectal Polyps , 2003, The American journal of surgical pathology.

[35]  Deborah Schrag,et al.  How much can current interventions reduce colorectal cancer mortality in the U.S.? , 2006, Cancer.

[36]  A. Schatzkin,et al.  Colonoscopic screening of average-risk women for colorectal neoplasia. , 2005, The New England journal of medicine.

[37]  J. Reguła,et al.  Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. , 2006, The New England journal of medicine.

[38]  W. Chiong Equipoise and the dilemma of randomized clinical trials. , 2011, The New England journal of medicine.

[39]  P. Rothwell,et al.  Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies , 2007, The Lancet.

[40]  Dawn Provenzale,et al.  Five-year colon surveillance after screening colonoscopy. , 2007, Gastroenterology.

[41]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[42]  A. Zauber,et al.  The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. , 1990, Gastroenterology.

[43]  Ennis,et al.  Correction: Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer. , 2000, The New England journal of medicine.

[44]  O. Kronborg,et al.  Influence of long-term colonoscopic surveillance on incidence of colorectal cancer and death from the disease in patients with precursors (adenomas) , 2007, Acta oncologica.

[45]  R. Sandler Editorial: Colonoscopy and Colorectal Cancer Mortality: Strong Beliefs or Strong Facts? , 2010, The American Journal of Gastroenterology.

[46]  L. Rabeneck,et al.  Association of Colonoscopy and Death From Colorectal Cancer , 2009, Annals of Internal Medicine.

[47]  S. Duffy,et al.  Estimating sensitivity and sojourn time in screening for colorectal cancer: a comparison of statistical approaches. , 1998, American journal of epidemiology.

[48]  J. Olsen,et al.  Randomised study of screening for colorectal cancer with faecal-occult-blood test , 1996, The Lancet.

[49]  M. Bretthauer The capsule and colorectal-cancer screening--the crux of the matter. , 2009, The New England journal of medicine.

[50]  A. Zauber,et al.  The national polyp study design, methods, and characteristics of patients with newly diagnosed polyps , 1992, Cancer.

[51]  S. Duffy,et al.  Colorectal cancer mass‐screening: Estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time , 1997, International journal of cancer.